A C.D.C. panel will meet today on the Johnson & Johnson vaccine pause.

The U.S. government is likely to end the pause if the panel says the vaccine’s benefits outweigh the potential risk.

source https://www.nytimes.com/2021/04/23/health/johnson-covid-vaccine-bloot-clots.html